This inventor holds 3 USPTO granted patents. Top assignee: Transgene S.a.. Active years: 1990-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-2000
Title: Sophie Jallat: Innovator in Biopharmaceuticals
Introduction
Sophie Jallat is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies. With a total of 3 patents to her name, her work has had a substantial impact on medical science.
Latest Patents
Sophie Jallat's latest patents include groundbreaking research on derivatives of human α1-antitrypsin. This invention focuses on an analog of human α1-antitrypsin characterized by specific amino acid modifications. Additionally, she has developed cell lines from transgenic mice that express biologically active human factor IX, controlled by hepatic cell-specific promoter regions. These advancements are crucial for producing therapeutic proteins that can be isolated from culture media.
Career Highlights
Sophie Jallat is currently associated with Transgene S.A., a company known for its innovative approaches in the biopharmaceutical sector. Her work has been instrumental in advancing therapeutic options for various diseases, showcasing her expertise and dedication to the field.
Collaborations
Some of her notable coworkers include Michael J. Courtney and Jean-Pierre Lecocq. Their collaborative efforts have further enhanced the research and development initiatives at Transgene S.A.
Conclusion
Sophie Jallat's contributions to biopharmaceuticals through her patents and collaborative work highlight her as a key figure in the industry. Her innovative research continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile